Presenting drug cost information to a board of directors: A case example

V. S. Crane, B. L. Hull, C. A. Hatwig, M. Teresi, C. L. Croft

Research output: Contribution to journalReview article

Abstract

Developing and implementing successful drug cost management strategies, projecting the budgetary impact of drugs, in the pipeline, and possessing a thorough understanding of the ever-changing underlying health care system are difficult enough tasks for most clinicians. Having to explain all these issues to a lay board of directors is even more challenging. This article presents a unique perspective - the actual 2002 drug cost containment report presented to Parkland Health & Hospital System's board of directors is shared. The report format and presentation style may serve as a model for others to follow who wish to not only keep their top executives informed about drug costs but also improve their relationships with these bottom-line oriented managers.

Original languageEnglish (US)
Pages (from-to)857-864
Number of pages8
JournalFormulary
Volume36
Issue number12
StatePublished - Jan 1 2001

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Presenting drug cost information to a board of directors: A case example'. Together they form a unique fingerprint.

  • Cite this

    Crane, V. S., Hull, B. L., Hatwig, C. A., Teresi, M., & Croft, C. L. (2001). Presenting drug cost information to a board of directors: A case example. Formulary, 36(12), 857-864.